Skip to main content
Log in

Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The induction of polyamine catabolism has been directly associated with the cytotoxic response of various tumor types to the antitumor polyamine analogues. Initially, human polyamine catabolism was assumed to be under the control of a rate-limiting spermidine/spermine N1-acetyltransferase (SSAT) that provides substrate for an acetylpolyamine oxidase (PAO). We have recently cloned a new polyamine analogue-inducible human polyamine oxidase (PAOh1/SMO) that efficiently uses spermine as a substrate. The induction of PAOh1/SMO in response to multiple polyamine analogues was examined in representative lung tumor cell lines.

Methods

Representatives of three different classes of antitumor polyamine analogues were examined for their ability to induce PAOh1/SMO.

Results

The human adenocarcinoma line, NCI A549 was found to be the most responsive line with respect to induction of PAOh1/SMO in response to analogue exposure. Similar to previous observations with SSAT expression, PAOh1/SMO induction was found to occur primarily in non-small-cell lung cancers cell lines. Using a series of polyamine analogues, it was found that the most potent inducers of PAOh1/SMO possessed multiple three-carbon linkers between nitrogens, as typified by N1,N11-bis(ethyl)norspermine.

Conclusions

Since PAOh1/SMO is an analogue-inducible enzyme that produces H2O2 as a metabolic product, it may play a significant role in determining the sensitivity of various human tumors to specific polyamine analogues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3A, B.
Fig. 4A, B.
Fig. 5A, B.
Fig. 6.
Fig. 7.

Similar content being viewed by others

Abbreviations

BENSpm:

N1,N11-bis(ethyl)norspermine

CHENSpm:

N1-ethyl-N11-(cycloheptyl)methyl-4,8,diazaundecane

CPENSpm:

N1-ethyl-N11-(cyclopropyl)methyl-4,8,diazaundecane

DAO:

Diamine oxidase

IPENSpm:

(S)-N1-(2-methyl-1-butyl)-N11-ethyl-4,8,diazaundecane

MAO:

Monoamine oxidase

MDL 72,527:

(N1,N4-bis(2,3-butadienyl)-1,4-butanediamine)

PAO:

Acetylpolyamine oxidase

PAOh1/SMO:

Human polyamine oxidase h1/spermine oxidase

SSAT:

Spermidine/spermine N1-acetyltransferase

References

  1. Bergeron RJ, Neims AH, McManis JS, Hawthorne TR, Vinson JR, Bortell R, Ingeno MJ (1988) Synthetic polyamine analogues as antineoplastics. J Med Chem 31:1183

    CAS  PubMed  Google Scholar 

  2. Bergeron RJ, Feng Y, Weimar WR, McManis JS, Dimova H, Porter C, Raisler B, Phanstiel O (1997) A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics. J Med Chem 40:1475

    Article  CAS  PubMed  Google Scholar 

  3. Bey P, Bolkenius FN, Seiler N, Casara P (1985) N-2,3-Butadienyl-1,4-butanediamine derivatives: potent irreversible inactivators of mammalian polyamine oxidase. J Med Chem 28:1

    CAS  PubMed  Google Scholar 

  4. Bolkenius FN, Bey P, Seiler N (1985) Specific inhibition of polyamine oxidase in vivo is a method for the elucidation of its physiological role. Biochim Biophys Acta 838:69

    Article  CAS  PubMed  Google Scholar 

  5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248

    Article  CAS  PubMed  Google Scholar 

  6. Casero RA, Pegg AE (1993) Spermidine/spermine N1-acetyltransferase—the turning point in polyamine metabolism. FASEB J 7:653

    CAS  PubMed  Google Scholar 

  7. Casero RA, Woster PM (2001) Terminally alkylated polyamine analogues as chemotherapeutic agents. J Med Chem 44:1

    Article  CAS  PubMed  Google Scholar 

  8. Casero RA, Celano P, Ervin SJ, Porter CW, Bergeron RJ, Libby PR (1989) Differential induction of spermidine/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res 49:3829

    CAS  PubMed  Google Scholar 

  9. Casero RA, Celano P, Ervin SJ, Wiest L, Pegg AE (1990) High specific induction of spermidine/spermine N1-acetyltransferase in a human large cell lung carcinoma. Biochem J 270:615

    CAS  PubMed  Google Scholar 

  10. Casero RA, Mank AR, Xiao L, Smith J, Bergeron RJ, Celano P (1992) Steady-state messenger RNA and activity correlates with sensitivity to N1,N12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res 52:5359

    CAS  PubMed  Google Scholar 

  11. Casero RA, Mank AR, Saab NH, Wu R, Dyer WJ, Woster PM (1995) Growth and biochemical effects of unsymmetrically substituted polyamine analogues in human lung tumor cells. Cancer Chemother Pharmacol 36:69

    Article  CAS  PubMed  Google Scholar 

  12. Chen Y, Kramer DL, Diegelman P, Vujcic S, Porter CW (2001) Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells. Cancer Res 61:6437

    CAS  PubMed  Google Scholar 

  13. Coleman CS, Pegg AE (1997) Proteasomal degradation of spermidine/spermine N1-acetyltransferase requires the carboxyl-terminal glutamic acid residues. J Biol Chem 272:12164

    Article  CAS  PubMed  Google Scholar 

  14. Coleman CS, Pegg AE (2001) Polyamine analogues inhibit the ubiquitination of spermidine/spermine N1-acetyltransferase and prevent its targeting to the proteasome for degradation. Biochem J 358:137

    Article  CAS  PubMed  Google Scholar 

  15. Coleman CS, Huang H, Pegg AE (1995) Role of the carboxyl terminal matee sequence of spermidine/spermine N1-acetyltransferase in the activity and stabilization by the polyamine analog N1,N12-bis(ethyl)spermine. Biochemistry 34:13423

    CAS  PubMed  Google Scholar 

  16. Devereux W, Wang Y, Murray Stewart T, Hacker A, Smith R, Ward TD, Woster PA, Casero RA (2003) Induction of polyamine oxidase by polyamine analogues in multiple human tumor lines. Proc Am Assoc Cancer Res 44:831

    Google Scholar 

  17. Fogel-Petrovic M, Vujcic S, Brown PJ, Haddox MK, Porter CW (1996) Effects of polyamines, polyamine analogs, and inhibitors of protein synthesis on spermidine-spermine N1-acetyltransferase gene expression. Biochemistry 35:14436

    Article  CAS  PubMed  Google Scholar 

  18. Fogel-Petrovic M, Vujcic S, Miller J, Porter CW (1996) Differential post-transcriptional control of ornithine decarboxylase and spermidine-spermine N1-acetyltransferase by polyamines. FEBS Lett 391:89

    Article  CAS  PubMed  Google Scholar 

  19. Fogel-Petrovic M, Kramer DL, Vujcic S, Miller J, McManis JS, Bergeron RJ, Porter CW (1997) Structural basis for differential induction of spermidine/spermine N1-acetyltransferase activity by novel spermine analogs. Mol Pharmacol 52:69

    CAS  PubMed  Google Scholar 

  20. Ha HC, Woster PM, Yager JD, Casero RA (1997) The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci U S A 94:11557

    Article  CAS  PubMed  Google Scholar 

  21. Hahm HA, Ettinger DS, Bowling K, Hoker B, Chen TL, Zabelina Y, Casero RA (2002) Phase I study of N1,N11-diethylnorspermine in patients with non-small cell lung cancer. Clin Cancer Res 8:684

    CAS  PubMed  Google Scholar 

  22. Kabra PM, Lee HK, Lubich WP, Marton LJ (1986) Solid-phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reversed-phase liquid chromatography: improved separation systems for polyamines in cerebrospinal fluid, urine and tissue. J Chromatogr 380:19

    Article  CAS  PubMed  Google Scholar 

  23. Lawson KR, Marek S, Linehan JA, Woster PM, Casero RA, Payne CM, Gerner EW (2002) Detoxification of the polyamine analogue N1-ethyl-N11-[(cycloheptyl)methyl]-4,8-diazaundecane (Chenspm) by polyamine oxidase. Clin Cancer Res 8:1241

    CAS  PubMed  Google Scholar 

  24. Lindsay GS, Wallace HM (1999) Changes in polyamine catabolism in Hl-60 human promyelogenous leukaemic cells in response to etoposide-induced apoptosis. Biochem J 337:83

    Article  CAS  PubMed  Google Scholar 

  25. Mank-Seymour AR, Murray TR, Berkey KA, Xiao L, Kern S, Casero RA (1998) Two active copies of the X-linked gene spermidine/spermine N1-acetyltransferase (Ssat) in a female lung cancer cell line are associated with an increase in sensitivity to an antitumor polyamine analogue. Clin Cancer Res 4:2003

    CAS  PubMed  Google Scholar 

  26. Marton LJ, Pegg AE (1995) Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35:55

    CAS  PubMed  Google Scholar 

  27. McCloskey DE, Pegg AE (2000) Altered spermidine/spermine N1-acetyltransferase activity as a mechanism of cellular resistance to bis(ethyl)polyamine analogues. J Biol Chem 275:28708

    Article  CAS  PubMed  Google Scholar 

  28. Murray Stewart T, Wang Y, Devereux W, Casero R.A (2002) Cloning and characterization of human polyamine oxidase splice variants. Proc Am Assoc Cancer Res 43:1120

    Google Scholar 

  29. Niiranen K, Pietila M, Pirttila TJ, Jarvinen A, Halmekyto M, Korhonen VP, Keinanen TA, Alhonen L, Janne J (2002) Targeted disruption of spermidine/spermine N1-acetyltransferase gene in mouse embryonic stem cells. Effects on polyamine homeostasis and sensitivity to polyamine analogues. J Biol Chem 277:25323

    Article  CAS  PubMed  Google Scholar 

  30. Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48:759

    CAS  PubMed  Google Scholar 

  31. Porter CW, Ganis B, Libby PR, Bergeron RJ (1991) Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res 51:3715

    CAS  PubMed  Google Scholar 

  32. Porter CW, Bernacki RJ, Miller J, Bergeron RJ (1993) Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res 53:581

    CAS  PubMed  Google Scholar 

  33. Porter CW, Ganis B, Rustum Y, Wrzosek C, Kramer DL, Bergeron RJ (1994) Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine. Cancer Res 54:5917

    CAS  PubMed  Google Scholar 

  34. Reddy VK, Valasinas A, Sarkar A, Basu HS, Marton LJ, Frydman B (1998) Conformationally restricted analogues of N1,N12-bisethylspermine: synthesis and growth inhibitory effects on human tumor cell lines. J Med Chem 41:4723

    Article  CAS  PubMed  Google Scholar 

  35. Reddy VK, Sarkar A, Valasinas A, Marton LJ, Basu HS, Frydman B (2001) Cis-unsaturated analogues of 3,8,13,18,23-pentaazapentacosane (Be-4-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cell lines. J Med Chem 44:404

    Article  CAS  PubMed  Google Scholar 

  36. Seiler N (1995) Polyamine oxidase, properties and functions. Prog Brain Res 106:333

    CAS  PubMed  Google Scholar 

  37. Shappell NW, Miller JT, Bergeron RJ, Porter CW (1992) Differential effects of the spermine analog, N1,N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. Anticancer Res 12:1083

    CAS  PubMed  Google Scholar 

  38. Suzuki O, Matsumoto T, Katsumata Y (1984) Determination of polyamine oxidase activities in human tissues. Experientia 40:838

    CAS  PubMed  Google Scholar 

  39. Valasinas A, Sarkar A, Reddy VK, Marton LJ, Basu HS, Frydman B (2001) Conformationally restricted analogues of N1,N14-bisethylhomospermine (Be-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cells. J Med Chem 44:390

    Article  CAS  PubMed  Google Scholar 

  40. Vujcic S, Diegelman P, Bacchi CJ, Kramer DL, Porter CW (2002) Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin. Biochem J 367:665

    Article  CAS  PubMed  Google Scholar 

  41. Vujcic S, Liang P, Diegelman P, Kramer D, Porter CW (2003) Genomic identification and biochemical characterization of the mammalian polyamine oxidase involved in polyamine back-conversion. Biochem J 370:19

    Article  CAS  PubMed  Google Scholar 

  42. Wang Y, Devereux W, Woster PM, Stewart TM, Hacker A, Casero RA (2001) Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res 61:5370

    CAS  PubMed  Google Scholar 

  43. Wang Y, Murray-Stewart T, Devereux W, Hacker A, Frydman B, Woster PM, Casero RA (2003) Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem Biophys Res Commun 304:605

    Google Scholar 

  44. Webb HK, Wu Z, Sirisoma N, Ha HC, Casero RA, Woster PM (1999) 1-(N-Alkylamino)-11-(N-ethylamino)-4,8-diazaundecanes: simple synthetic polyamine analogues that differentially alter tubulin polymerization. J Med Chem 42:1415

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert A. Casero.

Additional information

This work was supported by NIH grants CA51085, CA58184, CA85509, and CA88843.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Devereux, W., Wang, Y., Stewart, T.M. et al. Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells. Cancer Chemother Pharmacol 52, 383–390 (2003). https://doi.org/10.1007/s00280-003-0662-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-003-0662-4

Keywords

Navigation